Table 1 Top chemicals correlated with up and down signatures in the connectivity map by using DEGs.
From: Pirenperone relieves the symptoms of fragile X syndrome in Fmr1 knockout mice
CMap name | Mean | n | Enrichment | p | Specificity | Percent non-null |
|---|---|---|---|---|---|---|
Thiamine | − 0.727 | 3 | − 0.96 | 0.00018 | 0 | 100 |
SC-560 | − 0.58 | 3 | − 0.899 | 0.00194 | 0.0121 | 100 |
Hycanthone | − 0.312 | 4 | − 0.803 | 0.00294 | 0.0168 | 50 |
Biperiden | − 0.355 | 5 | − 0.723 | 0.00348 | 0.1088 | 60 |
Myosmine | − 0.38 | 6 | − 0.665 | 0.00399 | 0.0111 | 83 |
Pirenperone | − 0.415 | 5 | − 0.711 | 0.00433 | 0 | 80 |
MK-886 | − 0.716 | 2 | − 0.936 | 0.00861 | 0 | 100 |
Bacitracin | − 0.582 | 3 | − 0.837 | 0.00861 | 0.0242 | 100 |
Vinburnine | − 0.413 | 4 | − 0.742 | 0.00871 | 0 | 75 |
Prestwick-983 | − 0.621 | 3 | − 0.834 | 0.00915 | 0.0206 | 100 |
Iohexol | − 0.416 | 4 | − 0.724 | 0.0118 | 0.0511 | 75 |
Chloropyrazine | − 0.515 | 4 | − 0.723 | 0.012 | 0.0195 | 75 |
Betazole | − 0.424 | 5 | − 0.628 | 0.01846 | 0.007 | 80 |
Rilmenidine | − 0.393 | 4 | − 0.694 | 0.01866 | 0.0274 | 75 |
Fenofibrate | − 0.412 | 3 | − 0.789 | 0.01913 | 0.0581 | 66 |
Eticlopride | − 0.282 | 4 | − 0.69 | 0.02003 | 0.0379 | 50 |
Oxolamine | − 0.222 | 4 | − 0.689 | 0.02029 | 0.0461 | 50 |
Lisuride | − 0.258 | 5 | − 0.614 | 0.02363 | 0.2869 | 60 |
Prestwick-857 | − 0.341 | 4 | − 0.673 | 0.02564 | 0.051 | 75 |
Chenodeoxycholic acid | − 0.444 | 4 | − 0.673 | 0.02564 | 0.1308 | 75 |
Bretylium tosilate | − 0.3 | 4 | − 0.671 | 0.02616 | 0.0385 | 50 |
Lovastatin | − 0.287 | 4 | − 0.667 | 0.02765 | 0.0388 | 50 |
Quipazine | − 0.237 | 4 | − 0.648 | 0.03648 | 0.0315 | 50 |
Clidinium bromide | − 0.491 | 4 | − 0.638 | 0.04116 | 0.0245 | 75 |
Harmol | − 0.433 | 4 | − 0.63 | 0.04603 | 0.1585 | 75 |